Results of a randomized, open-label, blinded-end-point trial show significantly improved medication adherence at 15 months and significant, albeit small, improvements in systolic blood pressure (SBP) and low-density lipoprotein cholesterol...
Results of a randomized, open-label, blinded-end-point trial show significantly improved medication adherence at 15 months and significant, albeit small, improvements in systolic blood pressure (SBP) and low-density lipoprotein cholesterol...
Results of a randomized,...